ABT
Price
$113.64
Change
+$0.17 (+0.15%)
Updated
Mar 28, 6:59 PM EST
19 days until earnings call
TMO
Price
$581.25
Change
+$1.82 (+0.31%)
Updated
Mar 28, 6:59 PM EST
26 days until earnings call
Ad is loading...

Analysis and predictions ABT vs TMO

Header iconABT vs TMO Comparison
Open Charts ABT vs TMOBanner chart's image
Abbott Laboratories
Price$113.64
Change+$0.17 (+0.15%)
Volume$1.34M
CapitalizationN/A
Thermo Fisher Scientific
Price$581.25
Change+$1.82 (+0.31%)
Volume$157.99K
CapitalizationN/A
View a ticker or compare two or three
ABT vs TMO Comparison Chart

Loading...

ABTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TMODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABT vs. TMO commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a StrongBuy and TMO is a StrongSell.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ABT: $113.66 vs. TMO: $581.21)
Brand notoriety: ABT: Notable vs. TMO: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 88% vs. TMO: 70%
Market capitalization -- ABT: $197.22B vs. TMO: $221.62B
ABT [@Medical Specialties] is valued at $197.22B. TMO’s [@Medical Specialties] market capitalization is $221.62B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 3 FA rating(s) are green whileTMO’s FA Score has 1 green FA rating(s).

  • ABT’s FA Score: 3 green, 2 red.
  • TMO’s FA Score: 1 green, 4 red.
According to our system of comparison, ABT is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 5 TA indicator(s) are bullish while TMO’s TA Score has 3 bullish TA indicator(s).

  • ABT’s TA Score: 5 bullish, 5 bearish.
  • TMO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABT is a better buy in the short-term than TMO.

Price Growth

ABT (@Medical Specialties) experienced а +1.93% price change this week, while TMO (@Medical Specialties) price change was -0.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.84%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was +4.27%.

Reported Earning Dates

ABT is expected to report earnings on Apr 17, 2024.

TMO is expected to report earnings on Apr 24, 2024.

Industries' Descriptions

@Medical Specialties (+0.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ABT with price predictions.
OPEN
A.I.dvisor published
a Summary for TMO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TMO($222B) has a higher market cap than ABT($197B). TMO has higher P/E ratio than ABT: TMO (37.62) vs ABT (34.87). TMO YTD gains are higher at: 9.571 vs. ABT (3.760). TMO has higher annual earnings (EBITDA): 11.1B vs. ABT (10.5B). TMO has more cash in the bank: 8.08B vs. ABT (7.28B). ABT has less debt than TMO: ABT (15.6B) vs TMO (34.9B). TMO has higher revenues than ABT: TMO (42.9B) vs ABT (40.1B).
ABTTMOABT / TMO
Capitalization197B222B89%
EBITDA10.5B11.1B95%
Gain YTD3.7609.57139%
P/E Ratio34.8737.6293%
Revenue40.1B42.9B93%
Total Cash7.28B8.08B90%
Total Debt15.6B34.9B45%
FUNDAMENTALS RATINGS
ABT vs TMO: Fundamental Ratings
ABT
TMO
OUTLOOK RATING
1..100
5868
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
3220
SMR RATING
1..100
5862
PRICE GROWTH RATING
1..100
5234
P/E GROWTH RATING
1..100
3044
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (13) in the Medical Specialties industry is somewhat better than the same rating for TMO (73). This means that ABT’s stock grew somewhat faster than TMO’s over the last 12 months.

TMO's Profit vs Risk Rating (20) in the Medical Specialties industry is in the same range as ABT (32). This means that TMO’s stock grew similarly to ABT’s over the last 12 months.

ABT's SMR Rating (58) in the Medical Specialties industry is in the same range as TMO (62). This means that ABT’s stock grew similarly to TMO’s over the last 12 months.

TMO's Price Growth Rating (34) in the Medical Specialties industry is in the same range as ABT (52). This means that TMO’s stock grew similarly to ABT’s over the last 12 months.

ABT's P/E Growth Rating (30) in the Medical Specialties industry is in the same range as TMO (44). This means that ABT’s stock grew similarly to TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTTMO
RSI
ODDS (%)
Bullish Trend 1 day ago
52%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
64%
Momentum
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
49%
MACD
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
49%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
63%
Declines
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 3 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 3 days ago
48%
Aroon
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Ad is loading...
ABTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TMODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RUSHA53.520.53
+1.00%
Rush Enterprises
BLX29.620.27
+0.92%
Banco Latinoamericano de Comercio Exterior SA
GIS69.970.31
+0.45%
General Mills
RIGL1.47-0.02
-1.34%
Rigel Pharmaceuticals
GDTC2.17-0.07
-3.12%
CytoMed Therapeutics Limited

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been closely correlated with IDXX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ABT jumps, then IDXX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
+0.16%
IDXX - ABT
66%
Closely correlated
+0.07%
MDT - ABT
61%
Loosely correlated
+0.26%
BAX - ABT
54%
Loosely correlated
+0.12%
SYK - ABT
52%
Loosely correlated
-0.23%
ZBH - ABT
50%
Loosely correlated
-0.48%
More

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with A. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
+0.32%
A - TMO
79%
Closely correlated
-1.26%
WAT - TMO
76%
Closely correlated
-0.28%
DHR - TMO
76%
Closely correlated
+0.38%
MTD - TMO
67%
Closely correlated
-0.34%
IQV - TMO
60%
Loosely correlated
+0.13%
More